Table 4 Glucose profile between patients with 1hPG < 155vs ≥ 155 mg/dL and with 2hPG < 140 mg/dLv ≥ 140 mg/dL
Glucose 1 h (mg/dL) | 1hPG | 2hPG | ||||||
|---|---|---|---|---|---|---|---|---|
n | < 155 | ≥ 155 | p-value | n | < 140 | ≥ 140 | p-value | |
1hPG [mg/dL, mean (SD)] | – | – | – | – | 656 | 143.4 (33.8) | 184.2 (30.8) | < 0.001 |
2hPG [mg/dL, mean (SD)] | 656 | 109.7 (21.4) | 137.7 (26.9) | < 0.001 | – | – | – | – |
Fasting glucose [mg/dL, mean (SD)] | 656 | 88.6 (9.5) | 98.0 (10.0) | < 0.001 | 656 | 91.3 (10.3) | 97.8 (10.8) | < 0.001 |
HbA1c [%, mean (SD)] | 656 | 5.3 (0.4) | 5.6 (0.4) | < 0.001 | 656 | 5.4 (0.4) | 5.6 (0.4) | < 0.001 |
Peptide C [ng/mL, mean (SD)] | 629 | 3.3 (1.1) | 3.9 (1.3) | < 0.001 | 629 | 3.5 (1.2) | 4.0 (1.3) | < 0.001 |
Homa-IR [median (IQR)] | 654 | 3.3 (2.4) | 4.3 (3.4) | < 0.001 | 654 | 3.4 (2.7) | 4.6 (3.1) | < 0.001 |
HOMA-β [median (IQR)] | 654 | 251.5 (216.0) | 212.1 (205.0) | 0.003 | 654 | 226.5 (204.3) | 237.0 (222.3) | 0.402 |
Insulinogenic index (median (IQR)) | 643 | 1.66 (1.54) | 1.02 (0.89) | < 0.001 | 643 | 1.42 (1.43) | 1.02 (0.88) | < 0.001 |